gdc

Clinical Trials

Clinical Trials to Improve AYA Outcomes
Clinical Trials
Dr. Michael Roth believes that enhanced clinical trial enrollment will improve survival and quality of life for AYAs, and stresses the need to determine and overcome barriers to AYA clinical trial enrollment.
Why Are Clinical Trials Important in the Fight Against Cancer?
Clinical Trials
Dr. Michael Roth explains why clinical trials are critical to improving overall patient outcomes, including survivorship and quality of life.
The Gift of Life After Skin Cancer: From Surgeon to Being a Patient
Clinical TrialsPatient StoriesSkin Cancer
After a lifetime of treating patients, Dr. David Crouch understood his own illness left little room for optimism as skin cancer returned again and again. As a last resort, he joined a clinical trial of a new immunotherapy that provided him a new lease on life. Today, after 2 years in remission, his mission is to educate people about this cancer and this immunotherapy.
Is CAR T-Cell Therapy Safe and Effective?
Cancer ResearchClinical TrialsImmunotherapy
Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Working Together to Improve Cancer Care: Being My Dad’s Caregiver While “Inside” the Pharmaceutical Industry
CaregiversClinical Trials
“I found out that although my professional experience helped, it did not prepare me to be a caregiver,” says Mark Reisanauer, Oncology Business Unit SVP of Astellas Pharma US.
Patient Misconceptions About Clinical Trials
Clinical TrialsMultiple Myeloma
Yelak Biru identifies some pervasive misconceptions and common barriers that exist regarding clinical trials.
Clinical Trials Program Empowers Patients with Blood Cancer to Find Novel Treatment Options
Clinical Trials
The Jason Carter Clinical Trials Program helps patients with blood cancers find and access clinical trials for free.
Why Are Clinical Trials Important?
Clinical Trials
Dr Andrey Antov believes it's important for patients to participate in clinical trials for a multitude of reasons, as clinical trials can benefit both the patient and the healthcare system as a whole.
Why Should I Consider Participating in a Clinical Trial for New Cancer Immunotherapies?
Cancer ResearchClinical TrialsImmunotherapy
According to the Cancer Research Institute, only 3% to 6% of eligible patients with cancer participate in clinical trials in the United States. Read the reasons why clinical trials are a great option to consider.
Lack of Diversity in Clinical Trials Hurts Patients and Drug Development
Clinical TrialsMultiple Myeloma
Despite the great advances in cancer therapies, only a small proportion of patients with cancer participate in clinical trials today. This has a detrimental effect on the development of new cancer drugs.
Page 1 of 2
Results 1 - 10 of 14

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country